Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol
Introduction Despite universal access to government-funded direct-acting antivirals (DAAs) in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting drug use; reducing the hepatitis C burden among people who inject drugs (PWID...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2024-07-01
|
| Reeks: | BMJ Open |
| Online toegang: | https://bmjopen.bmj.com/content/14/7/e083502.full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
